Cardiovascular Disease

Heart attack – post myocardial infarction
Congestive Heart Failure (CHF)
Atherosclerosis
Severe angina
Stroke
Peripheral Arterial Disease (PAD)
Leg ulcers

Cardiovascular disease, often referred to as “heart disease”, describes a broad range of conditions that affects both the heart and the blood vessels. Heart disease is the number one killer of both men and women worldwide. Every thirty-three seconds in the United States, a person dies from cardiovascular disease.

Conditions typically involve the narrowing or blockage of arteries that bring blood to the heart (coronary arteries), brain (carotid arteries), or the lower limbs (femoral arteries) which can lead to heart attacks, chest pain, angina, stroke or peripheral arterial disease.

Other conditions such as infections, non-controlled high blood pressure or longstanding use of certain medications and drugs can impair the ability of the heart to pump correctly, resulting in congestive heart failure.

Physicians and scientists recognize that myocardial regeneration is possible and attainable. Endothelial progenitors cells (EPCs), show great promise and there is accumulating evidence that these cells can play an important role in vascular repair. These progenitor cells can be mobilized into the peripheral blood through the injections of specific growth factor. (The same cells are also present in the umbilical cord blood.)

Cellulogix offers stem cell treatment for cardiovascular diseases with the collection of peripheral blood stem cells through aphaeresis. The final procedure is non-invasive and consist of an intravenous infusion of precursors of cardiovascular stem cells.

Cell therapy is combined with a holistic comprehensive approach. The entire treatment takes five days to complete and includes lifestyle and diet recommendations, personalized natural supplements, prescriptions for atherosclerosis reduction, and cardiovascular protection.

Post stem cell treatment, patients are asked to submit laboratory tests and studies for cardiac function follow up.

Industry News

Stanford University Awarded over $5M for Research

Stanford University Medical Center. Four researchers at the Stanford University School of Medicine have been awarded just over $5.5 million for their stem cell research projects.
The California Institute for Regenerative Medicine is now funding projects that are attempting to find ways to overcome immune system rejection of transplanted stem cells. The institute is the state [...]

Read More

Patient Shares Comments Re: His Progress Since Treatment for Ataxia

Dear Cellulogix:   I’m Phil D. and I had my transplant the week of May 5th 2009.  We have communicated several times in the past but not lately. I had my 13th month post transplant exam with my Neurologist yesterday June 18th and thought Dr.Nabavi and you would be interested in an update on my condition. [...]

Read More

New Stem Cell Center At UC Irvine

Hub of hope and healing
Dedication of UCI’s Gross Hall is milestone in effort to unlock stem cells’ potential
 Daniel A. Anderson / University Communications
The May 14 dedication of UCI’s Sue & Bill Gross Hall: A CIRM Institute was a milestone in the effort to unlock stem cells’ potential. Here, CIRM fellows are briefed before leading guest [...]

Read More

Need to Send Medical Records?

Cellulogix recently added the Doc’s@cellulogix email address for our patients to send in their medical reports and all other pertinent information that may be requested. This is helpful if you want our team of specialists to have your medical information prior to your initial consultation as well as follow up reports that are requested.

Read More